All-Cause Mortality and Gastrointestinal Adverse Effects in Adults With Type 2 Diabetes on Glucagon-Like Peptide-1 Receptor Agonists vs Sodium-Glucose Cotransporter-2 Inhibitors. - Garg S; Qapaja T; Hamid O; Kaya G; Abdel-Razeq R; Alayan D; Abu-Rumaileh M; Lembo A; Nissen S (Gastro hep advances, 2025)